These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4315524)

  • 1. Studies on the biochemical characterization of human ceruloplasmin.
    Needleman SB; Sahgal V; Boshes B
    Experientia; 1970 May; 26(5):495-6. PubMed ID: 4315524
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on ceruloplasmin in Wilson's disease.
    Sahgal V; Needleman SB; McKelvey EM; Boshes B
    Neurology; 1970 Apr; 20(4):402-3. PubMed ID: 4998072
    [No Abstract]   [Full Text] [Related]  

  • 3. Ceruloplasmin in Wilson's disease.
    Holtzman NA; Naughton MA; Iber FL; Gaumnitz BM
    J Clin Invest; 1967 Jun; 46(6):993-1002. PubMed ID: 6026104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pathology of ceruloplasmin.
    Neifakh SA; Vasiletz IM; Shavlovsky MM
    Biochem Genet; 1972 Apr; 6(2):231-8. PubMed ID: 4199801
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular pathology of ceruloplasmin.
    Neifakh SA; Vasilets IM; Shavlovskii MM
    Mol Biol; 1971; 5(6):739-42. PubMed ID: 5005463
    [No Abstract]   [Full Text] [Related]  

  • 6. Isolation and partial characterization of the polypeptide chains in human ceruloplasmin.
    Simons K; Bearn AG
    Biochim Biophys Acta; 1969 Mar; 175(2):260-70. PubMed ID: 4976027
    [No Abstract]   [Full Text] [Related]  

  • 7. [Utilization of copper in the organism and its role in the pathogenesis of Wilson's disease].
    Marceau N
    Union Med Can; 1974 Dec; 103(12):2104-6. PubMed ID: 4619238
    [No Abstract]   [Full Text] [Related]  

  • 8. [Some observations on Wilson's disease].
    Fushimi H; Yokoda K; Shinji Y; Nasu T; Nishikawa M
    Nihon Rinsho; 1972 May; 30(5):1230-7. PubMed ID: 5065238
    [No Abstract]   [Full Text] [Related]  

  • 9. Evolution of the hepatic lesion in Wilson's disease (hepatolenticular degeneration).
    Sternlieb I
    Prog Liver Dis; 1972; 4():511-25. PubMed ID: 4569009
    [No Abstract]   [Full Text] [Related]  

  • 10. The biochemistry of copper.
    Frieden E
    Sci Am; 1968 May; 218(5):103-14. PubMed ID: 4297207
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of apo- and holo-forms of ceruloplasmin in patients with Wilson's disease using native polyacrylamide gel electrophoresis.
    Hirano K; Ogihara T; Ogihara H; Hiroi M; Hasegawa M; Tamai H
    Clin Biochem; 2005 Jan; 38(1):9-12. PubMed ID: 15607310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatolenticular degeneration: yesterday, today, tomorrow].
    Lazebnik LB; Sukhareva GV
    Eksp Klin Gastroenterol; 2007; (2):55-64. PubMed ID: 17539347
    [No Abstract]   [Full Text] [Related]  

  • 13. [Current views on the pathogenesis of Wilson's disease].
    Szeliga J
    Pediatr Pol; 1973 Mar; 48(3):381-4. PubMed ID: 4571542
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies of peptide maps of ceruloplasmin in Wilson's disease.
    Sahgal V; Needleman SB; Boshes B
    Trans Am Neurol Assoc; 1969; 94():335-6. PubMed ID: 4984978
    [No Abstract]   [Full Text] [Related]  

  • 15. [Copper, ceruloplasmin and the pathogenesis of hepatolenticular degeneration].
    Chromý K
    Cas Lek Cesk; 1965 Oct; 104(43):1173-7. PubMed ID: 5322100
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diagnostic and therapeutic experiences in Wilson's disease. I. Pathogenesis, biochemistry and clinical aspects of Wilson's disease].
    Eichner B; Biesold D; Günther K; Lössner J; Bachmann H; Diessner H
    Folia Clin Int (Barc); 1974 Oct; 24(10):696-707. PubMed ID: 4430389
    [No Abstract]   [Full Text] [Related]  

  • 17. [Serologic and hematologic findings in Wilson's disease].
    Engelmann L; Schneider D; von Baehr R
    Z Gesamte Inn Med; 1973 Jan; 28(1):17-21. PubMed ID: 4694331
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hygienic evaluation of the biological effect of pulsed electromagnetic fields of 850-2750 mHz].
    Tomashevskaia LA; Dumanskiĭ IuD
    Gig Sanit; 1988 Sep; (9):22-4. PubMed ID: 2853104
    [No Abstract]   [Full Text] [Related]  

  • 19. [Analysis of biochemical parameters in the diagnosis of Wilson's disease].
    Suquia Múgica B; Gilsanz Rodríguez F; Sánchez Rodríguez A; Querol Prieto R; Juanes González A; Martínez L de Letona J
    Rev Clin Esp; 1982 Jul 15-31; 166(1-2):29-33. PubMed ID: 7146516
    [No Abstract]   [Full Text] [Related]  

  • 20. Preparation of an apoprotein from ceruloplasmin by reversible dissociation of copper.
    MORELL AG; SCHEINBERG IH
    Science; 1958 Mar; 127(3298):588-90. PubMed ID: 13529022
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.